519 related articles for article (PubMed ID: 18724976)
1. How to ensure our readers' trust: the proper attribution of authors and contributors.
Liesegang TJ; Albert DM; Schachat AP
Am J Ophthalmol; 2008 Sep; 146(3):337-40. PubMed ID: 18724976
[No Abstract] [Full Text] [Related]
2. Authorship policy.
Novack GD
Am J Ophthalmol; 2009 Jan; 147(1):184; author reply 184-5. PubMed ID: 19100357
[No Abstract] [Full Text] [Related]
3. Impugning the integrity of medical science: the adverse effects of industry influence.
DeAngelis CD; Fontanarosa PB
JAMA; 2008 Apr; 299(15):1833-5. PubMed ID: 18413880
[No Abstract] [Full Text] [Related]
4. Publication ethics policies for medical journals.
Pai SA
Indian J Med Ethics; 2004; 1(3):93. PubMed ID: 16370089
[No Abstract] [Full Text] [Related]
5. Comment on: developing good scientific publishing practices: one pharmaceutical company's perspective.
Norris RA
Curr Med Res Opin; 2010 Jul; 26(7):1675-6. PubMed ID: 20450261
[No Abstract] [Full Text] [Related]
6. Promoting ethical conduct in the publication of research.
Freedman JE
Cardiovasc Ther; 2008; 26(2):89-90. PubMed ID: 18485131
[No Abstract] [Full Text] [Related]
7. Disclosure of conflicts of interest in biomedical publications.
Miller DR
Can J Anaesth; 2008 May; 55(5):265-7, 267-9. PubMed ID: 18451113
[No Abstract] [Full Text] [Related]
8. Sponsorship, authorship and accountability.
Davidoff F; DeAngelis CD; Drazen JM; Nicholls MG; Hoey J; Højgaard L; Horton R; Kotzin S; Nylenna M; Overbeke AJ; Sox HC; Van Der Weyden MB; Wilkes MS;
CMAJ; 2001 Sep; 165(6):786-8. PubMed ID: 11584570
[No Abstract] [Full Text] [Related]
9. [The journals must honestly tell who is doing the job].
Bergström R
Lakartidningen; 2008 May 7-13; 105(19):1406-7. PubMed ID: 18574981
[No Abstract] [Full Text] [Related]
10. Walking the Tightrope of Academia-Industry Relationships.
Editors
Ann Intern Med; 2015 Sep; 163(6):477-8. PubMed ID: 26168213
[No Abstract] [Full Text] [Related]
11. Ghost- and guest-authored pharmaceutical industry-sponsored studies: abuse of academic integrity, the peer review system, and public trust.
Flaherty DK
Ann Pharmacother; 2013; 47(7-8):1081-3. PubMed ID: 23585648
[TBL] [Abstract][Full Text] [Related]
12. Ghost story: at medical journals, writers paid by industry play big role.
Mathews AW
Wall St J (East Ed); 2005 Dec; ():A1, A8. PubMed ID: 16506304
[No Abstract] [Full Text] [Related]
13. Sponsorship, authorship and accountability.
Nichols G;
N Z Med J; 2001 Sep; 114(1139):391-2. PubMed ID: 11665924
[No Abstract] [Full Text] [Related]
14. [Ghostwriting].
Haug C
Tidsskr Nor Laegeforen; 2008 May; 128(9):1039. PubMed ID: 18451881
[No Abstract] [Full Text] [Related]
15. On transparency, responsibility, and accountability.
Paul M
Clin Microbiol Infect; 2009 Dec; 15(12):1100-2. PubMed ID: 19929974
[TBL] [Abstract][Full Text] [Related]
16. Ghostwriting in medical literature.
Int J Occup Environ Health; 2011; 17(2):168-77. PubMed ID: 21618949
[No Abstract] [Full Text] [Related]
17. The meaning of full disclosure. Collegial trust in science.
Freedman DX
Arch Gen Psychiatry; 1988 Jul; 45(7):689-91. PubMed ID: 3382326
[No Abstract] [Full Text] [Related]
18. Editorial policies on financial disclosure.
Carroll BJ; Rubin RT
Nat Neurosci; 2003 Oct; 6(10):999-1000; author reply 1000-1. PubMed ID: 14513028
[No Abstract] [Full Text] [Related]
19. Corporate versus public interests: community responsibility to defend scientific integrity.
Egilman DS; Druar NM
Int J Occup Environ Health; 2011; 17(2):181-5. PubMed ID: 21618951
[No Abstract] [Full Text] [Related]
20. Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation.
Ross JS; Hill KP; Egilman DS; Krumholz HM
JAMA; 2008 Apr; 299(15):1800-12. PubMed ID: 18413874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
